BASELINE SUV AND EARLY RESPONSE, BUT NOT MTV, ARE ASSOCIATED WITH OUTCOME IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED WITH NIVOLUMAB IN THE CHECKMATE 205 TRIAL
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 92-93
10.1002/hon.3163_56